These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients. Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986 [TBL] [Abstract][Full Text] [Related]
14. Posttransplant bronchiolitis obliterans syndrome. Where have we been and where are we going? Dauber JH Chest; 1996 Apr; 109(4):857-9. PubMed ID: 8635356 [No Abstract] [Full Text] [Related]
15. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279 [TBL] [Abstract][Full Text] [Related]
16. Obliterative bronchiolitis in the lung transplant recipient. A powerful foe. Smith-Seiler DA; Iacono AT Adv Nurse Pract; 2004 Apr; 12(4):69-74. PubMed ID: 15101139 [No Abstract] [Full Text] [Related]
17. Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome. Ikonen T; Kivisaari L; Harjula AL; Lehtola A; Heikkilä L; Kinnula VL; Kyösola K; Savola J; Sipponen J; Verkkala K; Mattila SP J Heart Lung Transplant; 1996 Jun; 15(6):587-95. PubMed ID: 8803756 [TBL] [Abstract][Full Text] [Related]
18. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? Hadjiliadis D; Davis RD; Palmer SM Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838 [TBL] [Abstract][Full Text] [Related]